Involvement of the endogenous cannabinoid 2 ligand 2-arachidonyl glycerol in allergic inflammation

International Archives of Allergy and Immunology

Volumn 159, Issue 2, 2012, Pages 149-156

  Mimura, Takayuki ^a   Oka, Saori ^b   Koshimoto, Hiroyuki ^a   Ueda, Yoshifumi ^a   Watanabe, Yoshihiro ^a   Sugiura, Takayuki ^b  

^a JAPAN TOBACCO INC   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

Author keywords

2 Arachidonyl glycerol; Allergic inflammation; Cannabinoid 2; Contact dermatitis; Microarray; Pulmonary bronchitis

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; 2 ARACHIDONOYLGLYCEROL; CHEMOKINE; ENDOCANNABINOID; ENDOCANNABINOID 2; LIGAND; OVALBUMIN; UNCLASSIFIED DRUG;

ALLERGY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHITIS; CELL GROWTH; CELL INFILTRATION; CELL STRAIN HL 60; CONTROLLED STUDY; DERMATITIS; DISEASE COURSE; DISEASE MODEL; DNA MICROARRAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATORY CELL; KNOCKOUT MOUSE; LUNG LAVAGE; MOUSE; NONHUMAN; OTITIS; PRIORITY JOURNAL; THICKNESS; UPREGULATION; WEIGHT GAIN;

ANIMALS; ARACHIDONIC ACIDS; BRONCHITIS; CANNABINOIDS; CHEMOKINES; CYTOKINES; DERMATITIS, ALLERGIC CONTACT; DISEASE MODELS, ANIMAL; ENDOCANNABINOIDS; FEMALE; GENE EXPRESSION; GLYCERIDES; GROWTH SUBSTANCES; HL-60 CELLS; HUMANS; HYPERSENSITIVITY; INFLAMMATION; LIGANDS; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; RECEPTOR, CANNABINOID, CB2;

EID: 84861624131     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000336167     Document Type: Article

References (26)

1. Munro S, Thomas KL, Abu-Shaar M: Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993; 365: 61-65.
2. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, Waku K: 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 1995; 215: 89-97.
3. Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR, Pertwee RG, Griffin G, Bayewitch M, Barg J, Vogel Z: Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 1995; 50: 83-90.
4. Galiegue S, Mary S, Marchand J, Dussossoy D, Carriere D, Carayon P, Bouaboula M, Shire D, Le Fur G, Casellas P: Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 1995; 232: 54-61.
5. Kishimoto S, Muramatsu M, Gokoh M, Oka S, Waku K, Sugiura T: Endogenous cannabinoid receptor ligand induces the migration of human natural killer cells. J Biochem 2005; 137: 217-223.
6. Kishimoto S, Gokoh M, Oka S, Muramatsu M, Kajiwara T, Waku K, Sugiura T: 2-Arachidonoylglycerol induces the migration of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes through the cannabinoid CB2 receptor-dependent mechanism. J Biol Chem 2003; 278: 24469-24475.
7. Oka S, Ikeda S, Kishimoto S, Gokoh M, Yanagimoto S, Waku K, Sugiura T: 2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils. J Leukoc Biol 2004; 76: 1002-1009.
8. Skaper SD, Buriani A, Dal Toso R, Petrelli L, Romanello S, Facci L, Leon A: The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. Proc Natl Acad Sci USA 1996; 93: 3984-3989.
9. Matias I, Pochard P, Orlando P, Salzet M, Pestel J, Di Marzo V: Presence and regulation of the endocannabinoid system in human dendritic cells. Eur J Biochem 2002; 269: 3771-3778.
10. Walter L, Franklin A, Witting A, Wade C, Xie Y, Kunos G, Mackie K, Stella N: Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J Neurosci 2003; 23: 1398-1405.
11. Gonsiorek W, Lunn C, Fan X, Narula S, Lundell D, Hipkin RW: Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide. Mol Pharmacol 2000; 57: 1045-1050.
12. Richardson D, Pearson RG, Kurian N, Latif ML, Garle MJ, Barrett DA, Kendall DA, Scammell BE, Reeve AJ, Chapman V: Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis. Arthritis Res Ther 2008; 10:R43.
13. Buckley NE, McCoy KL, Mezey E, Bonner T, Zimmer A, Felder CC, Glass M, Zimmer A: Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor. Eur J Pharmacol 2000; 396: 141-149.
14. Bligh EG, Dyer WJ: A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37: 911-917.
15. Tomimori Y, Muto T, Fukami H, Saito K, Horikawa C, Tsuruoka N, Saito M, Sugiura N, Yamashiro K, Sumida M, Kakutani S, Fukuda Y: Chymase participates in chronic dermatitis by inducing eosinophil infiltration. Lab Invest 2002; 82: 789-794.
16. Bligh EG, Dyer WJ: A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37: 911-917.
17. Kondo S, Kondo H, Nakane S, Kodaka T, Tokumura A, Waku K, Sugiura T: 2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist: identification as one of the major species of monoacylglycerols in various rat tissues, and evidence for its generation through CA2 + -dependent and -independent mechanisms. FEBS Lett 1998; 429: 152-156.
18. Kishimoto S, Kobayashi Y, Oka S, Gokoh M, Waku K, Sugiura T: 2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces accelerated production of chemokines in HL-60 cells. J Biochem 2004; 135: 517-524.
19. Jbilo O, Derocq JM, Segui M, Fur GL, Casellas P: Stimulation of peripheral cannabinoid receptor CB2 induces MCP-1 and IL-8 gene expression in human promyelocytic cell HL-60. FEBS Lett 1999; 448: 273-277.
20. Frazier K, Williams S, Kothapalli D, Klapper H, Grotendorst GR: Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol 1996; 107: 404-411.
21. Piao HM, Yamauchi K, Pan LH, Nakadate T, Ito H, Mouri T, Kobayashi H, Sawai T, Nakanishi T, Takigawa M, Inoue H: Increased levels of CTGF mRNA expression in a murine model of allergic airway inflammation. Allergol Int 2005; 54: 107-115.
22. Wu M, Melichian DS, de la Garza M, Gruner K, Bhattacharyya S, Barr L, Nair A, Shahrara S, Sporn PH, Mustoe TA, Tourtellotte WG, Varga J: Essential roles for early growth response transcription factor EGR-1 in tissue fibrosis and wound healing. Am J Pathol 2009; 175: 1041-1055.
23. Zhao Q, He Z, Chen N, Cho YY, Zhu F, Lu C, Ma WY, Bode AM, Dong Z: 2-Arachidonoylglycerol stimulates activator protein-1-dependent transcriptional activity and enhances epidermal growth factor-induced cell transformation in JB6 P+ cells. J Biol Chem 2005; 280: 26735-26742.
24. Doyle HA, Murphy JW: MIP-1 alpha contributes to the anticryptococcal delayedtype hypersensitivity reaction and protection against Cryptococcus neoformans. J Leukoc Biol 1997; 61: 147-155.
25. Russo C, Polosa R: TNF- as a promising therapeutic target in chronic asthma: a lesson from rheumatoid arthritis. Clin Sci (Lond) 2005; 109: 135-142.
26. Henderson WR Jr, Tang LO, Chu SJ, Tsao SM, Chiang GK, Jones F, Jonas M, Pae C, Wang H, Chi EY: A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am J Respir Crit Care Med 2002; 165: 108-116.